CD8A and cancer: Possibly, this could be a consequence of myofibroblast signaling or T cell-ECM interaction, as cancer associated myofibroblasts have been shown to suppress CD8+ T cell cytotoxicity,33 which has also been suggested for tumor ECM stiffness.34